Company: GOOGL
Filing Date: 2025-02-05
Form Type: 10-K
Source: 0001652044-25-000014
Chunk: 41

Company: Alphabet Inc.
Filing Date: 2025-02-05
Form: 10-K
Item: Item 8
Chunk 41
---
 net gain (loss) on marketable equity securities(3,242)790 156 Unrealized net gain (loss) on non-marketable equity securities(1)229 (1,088)3,372 Total gain (loss) on equity securities in other income (expense), net$(3,455)$392 $3,714 (1)Unrealized gain (loss) on non-marketable equity securities accounted for under the measurement alternative is comprised of $3.3 billion, $1.8 billion, and $5.6 billion of upward adjustments and $3.0 billion, $2.9 billion, and $2.2 billion of downward adjustments (including impairments) for the years ended December 31, 2022, 2023, and 2024, respectively.In the table above, realized net gain (loss) on equity securities sold during the period reflects the difference between the sale proceeds and the carrying value of the equity securities at the beginning of the period or the purchase date, if later. Cumulative net gains (losses) on equity securities sold during the period, which is summarized in the following table (in millions), represents the total net gains (losses) recognized after the initial purchase date of the equity security sold during the period. While these net gains (losses) may have been reflected in periods prior to the period of sale, we believe they are important supplemental information as they reflect the economic net gains (losses) on the securities sold during the period. Cumulative net gains (losses) are calculated as the difference between the sale price and the initial purchase price for the equity security sold during the period. 20232024Total sale price$1,981 $2,827 Total initial cost1,512 2,079 Cumulative net gains (losses)$469 $748 Equity Securities Accounted for Under the Equity Method

As of December 31, 2023 and 2024, equity securities accounted for under the equity method had a carrying value of approximately $1.7 billion and $2.0 billion, respectively. Our share of gains and losses, including impairments, are included as a component of OI&E, in the Consolidated Statements of Income. See Note 7 for further details on OI&E. Certain of our equity method securities include our investments in VIEs where we are not the primary beneficiary. See Note 4 for further details